BioSpace News Archive

Protecting patients is the FDA’s highest priority, and Americans can be confident in the quality of the products the agency approves.

Pulmonx Corporation, a leader in therapeutic pulmonary device technologies, announced today that its Zephyr® Valve is now covered by Priority Health® under its revised lung volume reduction coverage policy

The latter is an involved surgery where blood flow to the body, with the exception of the brain, is completely stopped for up to 45 minutes while the body is rapidly cooled to lower metabolism and oxygen usage.

Kewaunee Scientific Corporation announced its Board of Directors declared a quarterly cash dividend of nineteen cents per outstanding share, payable on September 24, 2019 to stockholders of record at the close of business on September 10, 2019.

August marks the annual observance of National Immunization Awareness Month, but as schoolchildren return to the classroom, a new analysis from the Center for Health Analytics, Research and Transformation (CHART) at the New Jersey Hospital Association shows a growing number of New Jersey students receiving exemptions from the minimum required vaccinations.

Phase 3 BouNDless study investigating the efficacy, safety and tolerability of ND0612, a potential non-surgical, subcutaneous continuous treatment, compared to oral immediate-release carbidopa/levodopa in people with Parkinson’s disease experiencing motor fluctuations.

Hyundai Hope On Wheels®, a 501 nonprofit organization, hosts the “Hands on Hope: 50 Hours for $50,000" competition in honor of National Childhood Cancer Awareness month.

Cancer Insight is Instrumental in Securing CPRIT Funding for Companies Developing Novel Cancer Treatments

In late August it was announced that Klaas Bakker was appointed as the new Chief Medical Officer for Oncopeptides.

The launch in Plano, Texas will provide a new resource for parents and kids seeking a more intensive, individualized, early approach to therapy